Mathematical Modeling of COVID-19 Dynamics under Two Vaccination Doses and Delay Effects
Abstract
:1. Introduction
2. Construction of the Mathematical Model
- The change in at time t is given by the inflow of new susceptibles and outflow of a proportion of first-dose vaccines at a rate of the form the proportion infected due to the force of infection given by , and the proportion of deaths naturally by the death rate which is It follows that
- The variation of is given by the inflow of susceptibles vaccinated with the first dose and the outflow of the proportion of first-time vaccinees when there is the interaction with the force of infection , plus the proportion of those vaccinated with the second dose , and, in addition, those vaccinated who die naturally at a rate d. One obtains
- The variation of will consist of the entry of those vaccinated with the second dose and the exit of a proportion of individuals who have been given the second dose but become infected due to interaction with the force of infection and exit, and, also, people die naturally at a rate d. Thus, we obtain the equation
- On the other hand, the variation of is given by the inflow of new infectees which is represented by the expression
- Variations of and , , and , respectively, will first consist of individuals who are infected and initially remain in the latent stage E for a certain time with mean , and a proportion a of latent individuals enter the asymptomatic class in a proportion . The remaining proportion of latent individuals develop the symptoms of the disease and pass into the infected class in a proportion of . The population in the asymptomatic class transits at a rate to the recovered class , that is, the factor leaves and enters . Similarly, infected persons I can pass into the recovered class R at a rate in a proportion and enter . Now, a part of the infected persons I can pass into the hospitalized class H at a rate h in a factor . In addition, it is possible that infected and asymptomatic die naturally at a rate d. Thus, we obtain the equations
- The variations of and , , and , respectively, are given by the transition to class H of class I with a factor of infected individuals who are hospitalized. The and arefactors of infected and asymptomatic individuals who recover enter the class R, that is, with a factor . Persons of class H hospitalized die from the virus at a rate , that is, they come out with a factor of , as well as the recovery of a percentage of those hospitalized at a rate , that is, they enter the class R with a factor . In addition, it is possible that they die naturally hospitalized and recovered at a rate d. From all of the above, the equations are
3. Existence and Uniqueness of the Model Solution
3.1. Positivity of Model Solutions
- , . Suppose that there exists such that , and for all , so that
- . To show that for all , let us reason by contradiction. We assume that there exists such that , and for all . Thus,
- (i)
- because for all
- (ii)
Therefore, and from (i) and (ii)
3.2. Boundedness of the Solutions
- If , then
- If , then
4. Stability Analysis
4.1. Disease-Free Equilibrium Point
4.2. Basic Reproduction Number
4.3. Endemic Equilibrium Point
- , , , ;
- , , , ;
- , , , ;
4.4. Local Stability in
- Case . Then, Equation (36) reduces toProof.Thus, by Theorem 6, has roots with a negative real part, and from Equation (38),Given it is clear that and . Therefore, using (37), it follows that , , and . Thus, whenever , all the coefficients of the equationTheorem 7Let be defined by (17). If then the equilibrium point is asymptotically stable for
- Case . From (36), we study the roots of the equationsProof.For this, we use the following lemma whose proof can be found in [57].Lemma 1.Let p and q be real numbers. Then, all the roots of the equation have negative real part if and only if the following conditions are satisfied:Since then with□The local stability in the endemic point is given by the following. The characteristic equation obtained for the pointTherefore, we obtain thatOtherwise,Finally, the expressions for are given byThe following cases are analyzed:
- −
- Now, first, we study the roots of the polynomial given by (54). Indeed, if we suppose thatThen, Equation (58) has six sign changes between its terms and, by Descartes’ rule of signs, it is concluded that there are six negative roots of Equation (57), that is, the polynomial given in (54) has roots with negative real part, and, from Equation (53),Therefore, the equilibrium point is asymptotically stable for .
- −
- Case . From (48), it is clear that (59) holds. Therefore, it is enough to study the roots of the equationSuppose that Equation (61) has a pair of purely imaginary conjugate roots . Substituting into (61) and separating the real and imaginary parts, one obtains thatIf , by combining the equations in (62) appropriately, it is verified thatSquaring both sides of the equations in (64) and adding them, we obtain thatNext, letNext, with the parameters given in (49), we obtain the following constants:Finally, given the , in (68), ifOn the other hand, without loss of generality, assume that Equation (70) has 12 positive roots, say , . Let , . Thus, for of system (64), one can obtain the corresponding such that equation (61) has a pair of purely imaginary roots, , given by.Thus,We denoteAfter performing some algebraic manipulations (see [58]), we obtain
For all of the above, we have the following result.Theorem 9..
4.5. Local Stability in
5. Numerical Solutions
- From Figure 2, it can be seen that when , that which is established in Theorem 7 is verified. In this case, the solutions tend to the equilibrium point defined in (14), and the behavior is stable. From a biological point of view, based on the chosen parameter values, if the susceptible population is subject to the vaccination process, growth is noted in the vaccinated subpopulations.
- In Figure 3, the validity of Theorem 9 is verified. In this case, the solutions tend to the equilibrium point and the behavior is stable.
- From Figure 4 and Figure 5, it can be seen that for the parameters established with , that which is established in Theorem 8 is verified.In this case, the solutions and are periodic when is around the threshold value . Therefore, system (1) has a periodic solution branch that bifurcates from equilibrium near .
6. Conclusions
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Abila, D.B.; Dei-Tumi, S.D.; Humura, F.; Aja, G.N. We need to start thinking about promoting the demand, uptake, and equitable distribution of COVID-19 vaccines NOW! Public Health Pract. 2020, 1, 100063. [Google Scholar] [CrossRef]
- Moghadas, S.M.; Vilches, T.N.; Zhang, K.; Nourbakhsh, S.; Sah, P.; Fitzpatrick, M.C.; Galvani, A.P. Evaluation of COVID-19 vaccination strategies with a delayed second dose. PLoS Biol. 2021, 19, e3001211. [Google Scholar]
- Ao, D.; Lan, T.; He, X.; Liu, J.; Chen, L.; Baptista-Hon, D.T.; Zhang, K.; Wei, X. SARS-CoV-2 Omicron variant: Immune escape and vaccine development. MedComm 2022, 3, e126. [Google Scholar] [CrossRef] [PubMed]
- Bushman, M.; Kahn, R.; Taylor, B.P.; Lipsitch, M.; Hanage, W.P. Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape. Cell 2021, 184, 6229–6242. [Google Scholar] [PubMed]
- Clemente-Suárez, V.J.; Hormeño-Holgado, A.; Jiménez, M.; Benitez-Agudelo, J.C.; Navarro-Jiménez, E.; Perez-Palencia, N.; Maestre-Serrano, R.; Laborde-Cárdenas, C.C.; Tornero-Aguilera, J.F. Dynamics of population immunity due to the herd effect in the COVID-19 pandemic. Vaccines 2020, 8, 236. [Google Scholar]
- Dyson, L.; Hill, E.M.; Moore, S.; Curran-Sebastian, J.; Tildesley, M.J.; Lythgoe, K.A.; House, T.; Pellis, L.; Keeling, M.J. Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics. Nat. Commun. 2021, 12, 5730. [Google Scholar] [CrossRef]
- Gonzalez-Parra, G.; Arenas, A.J. Nonlinear dynamics of the introduction of a new SARS-CoV-2 variant with different infectiousness. Mathematics 2021, 9, 1564. [Google Scholar] [CrossRef]
- Harvey, W.T.; Carabelli, A.M.; Jackson, B.; Gupta, R.K.; Thomson, E.C.; Harrison, E.M.; Ludden, C.; Reeve, R.; Rambaut, A.; Peacock, S.J.; et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 2021, 19, 409–424. [Google Scholar] [CrossRef]
- Murray, J.D. Mathematical Biology I: An Introduction, Volume 17 of Interdisciplinary Applied Mathematics; Springer: New York, NY, USA, 2002. [Google Scholar]
- Keener, J.P. Biology in Time and Space: A Partial Differential Equation Modeling Approach; American Mathematical Society: Ann Arbor, MI, USA, 2021; Volume 50. [Google Scholar]
- Frassu, S.; Galván, R.R.; Viglialoro, G. Uniform in time L∞-estimates for an attraction-repulsion chemotaxis model with double saturation. Discret. Contin. Dyn. Syst.-B 2023, 28, 1886–1904. [Google Scholar]
- Grave, M.; Viguerie, A.; Barros, G.F.; Reali, A.; Coutinho, A.L. Assessing the spatio-temporal spread of COVID-19 via compartmental models with diffusion in Italy, USA, and Brazil. Arch. Comput. Methods Eng. 2021, 28, 4205–4223. [Google Scholar]
- Guglielmi, N.; Iacomini, E.; Viguerie, A. Delay differential equations for the spatially resolved simulation of epidemics with specific application to COVID-19. Math. Methods Appl. Sci. 2022, 45, 4752–4771. [Google Scholar] [CrossRef]
- Ayoub, H.H.; Chemaitelly, H.; Abu-Raddad, L.J. Epidemiological Impact of Novel Preventive and Therapeutic HSV-2 Vaccination in the United States: Mathematical Modeling Analyses. Vaccines 2020, 8, 366. [Google Scholar] [CrossRef] [PubMed]
- Benest, J.; Rhodes, S.; Quaife, M.; Evans, T.G.; White, R.G. Optimising Vaccine Dose in Inoculation against SARS-CoV-2, a Multi-Factor Optimisation Modelling Study to Maximise Vaccine Safety and Efficacy. Vaccines 2021, 9, 78. [Google Scholar] [CrossRef] [PubMed]
- Gozalpour, N.; Badfar, E.; Nikoofard, A. Transmission dynamics of novel coronavirus SARS-CoV-2 among healthcare workers, a case study in Iran. Nonlinear Dyn. 2021, 105, 3749–3761. [Google Scholar] [CrossRef] [PubMed]
- Martinez-Rodriguez, D.; Gonzalez-Parra, G.; Villanueva, R.J. Analysis of key factors of a SARS-CoV-2 vaccination program: A mathematical modeling approach. Epidemiologia 2021, 2, 140–161. [Google Scholar] [CrossRef]
- Yang, H.M.; Junior, L.P.L.; Castro, F.F.M.; Yang, A.C. Evaluating the impacts of relaxation and mutation in the SARS-CoV-2 on the COVID-19 epidemic based on a mathematical model: A case study of São Paulo State (Brazil). Comput. Appl. Math. 2021, 40, 272. [Google Scholar] [CrossRef]
- Babasola, O.; Kayode, O.; Peter, O.J.; Onwuegbuche, F.C.; Oguntolu, F.A. Time-delayed modelling of the COVID-19 dynamics with a convex incidence rate. Inform. Med. Unlocked 2022, 35, 101124. [Google Scholar] [CrossRef]
- Dell’Anna, L. Solvable delay model for epidemic spreading: The case of Covid-19 in Italy. Sci. Rep. 2020, 10, 15763. [Google Scholar] [CrossRef]
- Devipriya, R.; Dhamodharavadhani, S.; Selvi, S. SEIR model FOR COVID-19 Epidemic using DELAY differential equation. In Proceedings of the Journal of Physics: Conference Series, Nanchang, China, 26–28 October 2021; IOP Publishing: Bristol, UK, 2021; Volume 1767, p. 012005. [Google Scholar]
- Gonzalez-Parra, G. Analysis of delayed vaccination regimens: A mathematical modeling approach. Epidemiologia 2021, 2, 271–293. [Google Scholar] [CrossRef]
- Paul, S.; Lorin, E. Estimation of COVID-19 recovery and decease periods in Canada using delay model. Sci. Rep. 2021, 11, 23763. [Google Scholar] [CrossRef]
- Pell, B.; Johnston, M.D.; Nelson, P. A data-validated temporary immunity model of COVID-19 spread in Michigan. Math. Biosci. Eng. 2022, 19, 10122–10142. [Google Scholar] [CrossRef]
- Shayak, B.; Sharma, M.M.; Gaur, M.; Mishra, A.K. Impact of reproduction number on multiwave spreading dynamics of COVID-19 with temporary immunity: A mathematical model. Int. J. Infect. Dis. 2021, 104, 649–654. [Google Scholar] [CrossRef]
- Shayak, B.; Sharma, M.M.; Rand, R.H.; Singh, A.; Misra, A. A Delay differential equation model for the spread of COVID-19. Int. J. Eng. Res. Appl. 2020, 10, 1–13. [Google Scholar]
- Benlloch, J.M.; Cortés, J.C.; Martínez-Rodríguez, D.; Julián, R.S.; Villanueva, R.J. Effect of the early use of antivirals on the COVID-19 pandemic. A computational network modeling approach. Chaos Solitons Fractals 2020, 140, 110168. [Google Scholar] [CrossRef] [PubMed]
- Bhadauria, A.S.; Pathak, R.; Chaudhary, M. A SIQ mathematical model on COVID-19 investigating the lockdown effect. Infect. Dis. Model. 2021, 6, 244–257. [Google Scholar] [CrossRef]
- Dobrovolny, H.M. Modeling the role of asymptomatics in infection spread with application to SARS-CoV-2. PLoS ONE 2020, 15, e0236976. [Google Scholar] [CrossRef]
- Hamou, A.A.; Rasul, R.R.; Hammouch, Z.; Özdemir, N. Analysis and dynamics of a mathematical model to predict unreported cases of COVID-19 epidemic in Morocco. Comput. Appl. Math. 2022, 41, 289. [Google Scholar] [CrossRef]
- González-Parra, G.; Díaz-Rodríguez, M.; Arenas, A.J. Mathematical modeling to study the impact of immigration on the dynamics of the COVID-19 pandemic: A case study for Venezuela. Spat. Spatio-Temporal Epidemiol. 2022, 43, 100532. [Google Scholar] [CrossRef] [PubMed]
- Mahrouf, M.; Boukhouima, A.; Zine, H.; Lotfi, E.M.; Torres, D.F.; Yousfi, N. Modeling and forecasting of COVID-19 spreading by delayed stochastic differential equations. Axioms 2021, 10, 18. [Google Scholar] [CrossRef]
- Pham, H. On estimating the number of deaths related to Covid-19. Mathematics 2020, 8, 655. [Google Scholar] [CrossRef]
- Pinter, G.; Felde, I.; Mosavi, A.; Ghamisi, P.; Gloaguen, R. COVID-19 pandemic prediction for Hungary; a hybrid machine learning approach. Mathematics 2020, 8, 890. [Google Scholar] [CrossRef]
- Dobrovolny, H.M. Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2. Virology 2020, 550, 61–69. [Google Scholar] [CrossRef]
- Fain, B.; Dobrovolny, H.M. Initial Inoculum and the Severity of COVID-19: A Mathematical Modeling Study of the Dose-Response of SARS-CoV-2 Infections. Epidemiologia 2020, 1, 5–15. [Google Scholar] [CrossRef]
- Ghosh, I. Within host dynamics of SARS-CoV-2 in humans: Modeling immune responses and antiviral treatments. SN Comput. Sci. 2021, 2, 482. [Google Scholar] [CrossRef] [PubMed]
- Dinleyici, E.C.; Borrow, R.; Safadi, M.A.P.; van Damme, P.; Munoz, F.M. Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum. Vaccines Immunother. 2021, 17, 400–407. [Google Scholar] [CrossRef]
- Haque, A.; Pant, A.B. Efforts at COVID-19 Vaccine Development: Challenges and Successes. Vaccines 2020, 8, 739. [Google Scholar] [CrossRef] [PubMed]
- Hodgson, S.H.; Mansatta, K.; Mallett, G.; Harris, V.; Emary, K.R.; Pollard, A.J. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect. Dis. 2021, 21, e26–e35. [Google Scholar] [CrossRef]
- Van den Driessche, P.; Watmough, J. Further Notes on the Basic Reproduction Number; Springer: Berlin/Heidelberg, Germany, 2008; pp. 159–178. [Google Scholar]
- Hale, J.K. Theory of Functional Differential Equations, 2nd ed.; Applied Mathematical Sciences 3; Springer: Berlin/Heidelberg, Germany, 1977. [Google Scholar]
- Nelson, R. COVID-19 disrupts vaccine delivery. Lancet Infect. Dis. 2020, 20, 546. [Google Scholar] [CrossRef]
- Weintraub, R.L.; Subramanian, L.; Karlage, A.; Ahmad, I.; Rosenberg, J. COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now: Analysis describe lessons learned from past pandemics and vaccine campaigns about the path to successful vaccine delivery for COVID-19. Health Aff. 2021, 40, 33–41. [Google Scholar] [CrossRef]
- Mahase, E. COVID-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows. BMJ 2020, 371, m4826. [Google Scholar] [CrossRef]
- Hasanoglu, I.; Korukluoglu, G.; Asilturk, D.; Cosgun, Y.; Kalem, A.K.; Altas, A.B.; Kayaaslan, B.; Eser, F.; Kuzucu, E.A.; Guner, R. Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg. Infection 2021, 49, 117–126. [Google Scholar] [CrossRef] [PubMed]
- Ferguson, N.; Laydon, D.; Nedjati Gilani, G.; Imai, N.; Ainslie, K.; Baguelin, M.; Bhatia, S.; Boonyasiri, A.; Cucunuba Perez, Z.; Cuomo-Dannenburg, G.; et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Imp. Coll. Lond. 2020, 10, 491–497. [Google Scholar]
- Kinoshita, R.; Anzai, A.; Jung, S.m.; Linton, N.M.; Miyama, T.; Kobayashi, T.; Hayashi, K.; Suzuki, A.; Yang, Y.; Akhmetzhanov, A.R.; et al. Containment, Contact Tracing and Asymptomatic Transmission of Novel Coronavirus Disease (COVID-19): A Modelling Study. J. Clin. Med. 2020, 9, 3125. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.; Wang, A.; Yi, B.; Ding, K.; Wang, H.; Wang, J.; Xu, G. The epidemiological characteristics of infection in close contacts of COVID-19 in Ningbo city. Chin. J. Epidemiol. 2020, 41, 668–672. [Google Scholar]
- Mc Evoy, D.; McAloon, C.G.; Collins, A.B.; Hunt, K.; Butler, F.; Byrne, A.W.; Casey, M.; Barber, A.; Griffin, J.M.; Lane, E.A.; et al. The relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: A rapid scoping review. medRxiv 2020. [Google Scholar] [CrossRef]
- Zhao, H.J.; Lu, X.X.; Deng, Y.B.; Tang, Y.J.; Lu, J.C. COVID-19: Asymptomatic carrier transmission is an underestimated problem. Epidemiol. Infect. 2020, 148, 1–7. [Google Scholar] [CrossRef]
- Fred Brauer, J.A.N. The Qualitative Theory of Ordinary Differential Equations: An Introduction; Dover Publications: Garden City, NY, USA, 1989. [Google Scholar]
- Van den Driessche, P.; Watmough, J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 2002, 180, 29–48. [Google Scholar] [CrossRef]
- Wang, X. A Simple Proof of Descartes’s Rule of Signs. Am. Math. Mon. 2004, 111, 525. [Google Scholar] [CrossRef]
- Karaaslanlı, C.Ç. Bifurcation Analysis and Its Applications; INTECH Open Access Publisher: London, UK, 2012. [Google Scholar]
- Krauskopf, B.; Sieber, J. Bifurcation analysis of systems with delays: Methods and their use in applications. In Controlling Delayed Dynamics; Springer: Berlin/Heidelberg, Germany, 2023; pp. 195–245. [Google Scholar]
- Bernard, S. Cell Population Dynamics—Lecture Notes; University Lyon Publishing: Lyon, France, 2021. [Google Scholar]
- Huang, Q.; Ma, Z. On stability of some transcendental equation. Ann. Diff. Eqs 1990, 6, 21–31. [Google Scholar]
- Shampine, L.F.; Thompson, S. Solving ddes in matlab. Appl. Numer. Math. 2001, 37, 441–458. [Google Scholar] [CrossRef]
- Shampine, L.F.; Thompson, S. Numerical solution of delay differential equations. In Delay Differential Equations; Springer: Berlin/Heidelberg, Germany, 2009; pp. 1–27. [Google Scholar]
- The World Bank. 2021. Available online: https://data.worldbank.org/ (accessed on 1 March 2022).
- Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.; Lau, E.H.; Wong, J.Y.; et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N. Engl. J. Med. 2020, 382, 1199–1207. [Google Scholar] [CrossRef] [PubMed]
- IHME COVID-19 Forecasting Team. Modeling COVID-19 scenarios for the United States. Nat. Med. 2021, 27, 94–105. [Google Scholar] [CrossRef] [PubMed]
- Lauer, S.A.; Grantz, K.H.; Bi, Q.; Jones, F.K.; Zheng, Q.; Meredith, H.R.; Azman, A.S.; Reich, N.G.; Lessler, J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann. Intern. Med. 2020, 172, 577–582. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hoseinpour Dehkordi, A.; Alizadeh, M.; Derakhshan, P.; Babazadeh, P.; Jahandideh, A. Understanding epidemic data and statistics: A case study of COVID-19. J. Med Virol. 2020, 92, 868–882. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Quah, P.; Li, A.; Phua, J. Mortality rates of patients with COVID-19 in the intensive care unit: A systematic review of the emerging literature. Crit. Care 2020, 24, 1–4. [Google Scholar] [CrossRef]
- Paltiel, A.D.; Schwartz, J.L.; Zheng, A.; Walensky, R.P. Clinical outcomes of a COVID-19 vaccine: Implementation over efficacy: Study examines how definitions and thresholds of vaccine efficacy, coupled with different levels of implementation effectiveness and background epidemic severity, translate into outcomes. Health Aff. 2021, 40, 42–52. [Google Scholar]
- Centers for Disease Control and Prevention. 2020. Available online: https://www.cdc.gov/coronavirus/2019-nCoV/index.html (accessed on 1 March 2022).
- Oran, D.P.; Topol, E.J. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review. Ann. Intern. Med. 2020, 173, 362–367. [Google Scholar] [CrossRef]
Parameter | Symbol | Value |
---|---|---|
Incubation period | year [62,63,64] | |
Infection period | year [62] | |
Hospitalization rate | h | year [47,62,65] |
Hospitalization period | year [47,62,65] | |
Death rate (hospitalized) | year [66,67] | |
Probability of being asymptomatic | a | [0.2–0.8] [68,69] |
Vaccine efficacy (first dose) | 0.52 [45] | |
Vaccine efficacy (second dose) | 0.95 [45] | |
Transmission rate between I and S | varied | |
Transmission rate between A and S | varied | |
Vaccination rate (first dose) | varied | |
Vaccination rate (second dose) | varied | |
Delay for immune protection | varied | |
Recruiting rate | 649,742 year [61] | |
Death rate | d | varied (year ) [61] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sepulveda, G.; Arenas, A.J.; González-Parra, G. Mathematical Modeling of COVID-19 Dynamics under Two Vaccination Doses and Delay Effects. Mathematics 2023, 11, 369. https://doi.org/10.3390/math11020369
Sepulveda G, Arenas AJ, González-Parra G. Mathematical Modeling of COVID-19 Dynamics under Two Vaccination Doses and Delay Effects. Mathematics. 2023; 11(2):369. https://doi.org/10.3390/math11020369
Chicago/Turabian StyleSepulveda, Gabriel, Abraham J. Arenas, and Gilberto González-Parra. 2023. "Mathematical Modeling of COVID-19 Dynamics under Two Vaccination Doses and Delay Effects" Mathematics 11, no. 2: 369. https://doi.org/10.3390/math11020369
APA StyleSepulveda, G., Arenas, A. J., & González-Parra, G. (2023). Mathematical Modeling of COVID-19 Dynamics under Two Vaccination Doses and Delay Effects. Mathematics, 11(2), 369. https://doi.org/10.3390/math11020369